Company Filing History:
Years Active: 2018-2022
Title: Fabrizio Montecucco: Innovator in Pharmaceutical Compositions
Introduction
Fabrizio Montecucco is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of diseases related to cholesterol levels. With a total of 2 patents, his work focuses on innovative compositions that utilize methyl cyclodextrins.
Latest Patents
Montecucco's latest patents include compositions based on methyl cyclodextrins aimed at increasing HDL cholesterol levels. The first patent discloses a pharmaceutical composition comprising at least one methyl cyclodextrin with a molar substitution degree between 0.05 and 1.5. This composition is designed for the treatment and prevention of diseases that can be addressed by raising HDL cholesterol levels. The second patent relates to a novel use of a similar pharmaceutical composition, emphasizing its potential in treating atherosclerosis and complications associated with atheroma, as well as diseases of the central nervous system. Additionally, these compositions can stimulate the reduction of circulating fatty acids and triglyceride levels, helping to prevent atheromatous plaques.
Career Highlights
Fabrizio Montecucco is currently associated with Roquette Freres, a company known for its expertise in food and pharmaceutical ingredients. His work at Roquette Freres has allowed him to explore and develop innovative solutions in the pharmaceutical sector.
Collaborations
Montecucco collaborates with esteemed colleagues such as Marc Salome and Daniel Wils. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Fabrizio Montecucco stands out as an influential inventor in the pharmaceutical industry, with a focus on enhancing health through innovative compositions. His contributions are paving the way for new treatments that can significantly impact patient care.